Apollo Therapeutics
Apollo Therapeutics is a portfolio of pharmaceutical research and discovery founded in 2016.
4
Funding Rounds
$529.0m
Money raised
Overview
Apollo Therapeutics is a portfolio of pharmaceutical research and discovery founded in 2016.
- Website:
- Headquarters: London
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Apollo Therapeutics has raised a total of $529m in funding over 4 rounds.
Key Insights:
- Apollo Therapeutics January 2024 Series C Funding Round: $34m
- Apollo Therapeutics September 2023 Series C Funding Round: $230m
- Apollo Therapeutics , June 2021: $145m
- Apollo Therapeutics June 2021 Series C Funding Round: $120m
Apollo Therapeutics January 2024 Series C Funding Round
$34m
Apollo Therapeutics September 2023 Series C Funding Round
$230m
Apollo Therapeutics , June 2021
$145m
Apollo Therapeutics June 2021 Series C Funding Round
$120m
Industries
Apollo Therapeutics is active in the following industries: